Effect of Obesity on Tear Film and Ocular Health Among Diabetic Patients

March 29, 2025 updated by: Muhammad Naveed Babur, Superior University

To evaluate the effect of obesity on tear film and ocular health in diabetic patients.

Research Design An observational cross-sectional study will be conducted.

Study Overview

Status

Active, not recruiting

Study Type

Observational

Enrollment (Actual)

120

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Punjab
      • Mandi Bahāuddīn, Punjab, Pakistan
        • Alvi Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Diabetic participants aged 18-70 with varying BMI categories will be assessed for tear production and film stability using Schirmer's Test and Tear Break-Up Time (TBUT). Demographics, medical history, and ocular health will also be recorded in a controlled clinic environment.

Description

Inclusion Criteria:

  • Adults (18+ years)
  • diagnosed with type 1 or type 2 diabetes
  • categorized as obese or non-obese (BMI >30 or <30)
  • stable glycemic control, and willing to provide consent.

Exclusion Criteria:

  • Non-diabetic individuals
  • pregnant/lactating women
  • those with recent ocular surgeries
  • systemic medications affecting tear film, or severe unrelated diseases.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The Oswestry Disability Index (ODI)
Time Frame: 12 Months
The Oswestry Disability Index (ODI) is a questionnaire used to assess functional disability in individuals with low back pain, with scores ranging from 0% (no disability) to 100% (maximum disability), and interpreted as follows: 0-20% minimal disability, 21-40% moderate, 41-60% severe, 61-80% crippling, and 81-100% bed-bound or exaggerated symptom
12 Months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 20, 2025

Primary Completion (Estimated)

June 20, 2025

Study Completion (Estimated)

February 20, 2026

Study Registration Dates

First Submitted

March 29, 2025

First Submitted That Met QC Criteria

March 29, 2025

First Posted (Actual)

April 6, 2025

Study Record Updates

Last Update Posted (Actual)

April 6, 2025

Last Update Submitted That Met QC Criteria

March 29, 2025

Last Verified

March 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe